Vanda Pharmaceuticals Inc. v. West Ward Pharmaceuticals


(United States Federal Circuit) – Affirming the decision of the district court holding, after a bench trial, that the asserted claims of a patent relating to the treatment of schizophrenia with iloperidone administered based on the genotype of the patient were infringed and not invalid.